Journals / Journal of Experimental and Clinical Medicine / 2020 / Cilt: 37 - Sayı: 4

Investigation of the antimicrobial effects of Sapindus mukorossi on endodontic pathogens

Pages
111–118
Publication Date
2020-09-11
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

S. mukorossi extract has interesting potential as an antimicrobial agent against endodontic pathogens.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Endodontic infections have a polymicrobial nature.
📊
Key Findings & Data:Antimicrobial inhibitory activity was observed with all four different solvent extracts of S. mukorossi against Fusobacterium nucleatum American Type Culture Collection (ATCC) 25586, Porphyromonas gingivalis ATCC 33277 and Actinomyces odontolyticus (clinical isolate).
💡
Conclusion & Impact:S. mukorossi extract has interesting potential as an antimicrobial agent against endodontic pathogens.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Actinomyces odontolyticus · antimicrobial · Candida albicans

Abstract

Endodontic infections have a polymicrobial nature. Thus, eliminating the microorganisms from infected root canals without damaging healthy surrounding tissue is a major concern. Sapindus mukorossi (S. mukorossi) is a natural product with potential antimicrobial effects. The aim of this study was to evaluate whether various extract solutions of S. mukorossi have an antimicrobial activity against specific endodontic pathogens. Extracts were obtained from S. mukorossi fruit pericarps using methanol, ethanol, butanol and distilled water solvents. The inhibition zone, minimum inhibitory concentration (MIC), minimum bactericidal concentration (MBC) and minimum fungicidal concentration (MFC) were determined with disc diffusion assay, broth microdilution assay and agar dilution assay. Antimicrobial inhibitory activity was observed with all four different solvent extracts of S. mukorossi against Fusobacterium nucleatum American Type Culture Collection (ATCC) 25586, Porphyromonas gingivalis ATCC 33277 and Actinomyces odontolyticus (clinical isolate). The MIC values were ranged 10.24-10.24, 0.01-0.64 and 1.28- 2.56 mg/mL, respectively. The MBC value was not detected for Fusobacterium nucleatum ATCC 25586. The MBC values were 0.02-1.25 and 2.56-5.12 mg/ mL for Porphyromonas gingivalis ATCC 33277 and Actinomyces odontolyticus (clinical isolate), respectively. Antifungal activities were also observed with the four different solvent extracts of S. mukorossi against Candida albicans ATCC 10231 and C. albicans clinical isolates 1, 2 and 3. The inhibition zone diameter values were in the range of 18-21 mm. The MIC values for C. albicans ATCC 10231 and C. albicans clinical isolates 1, 2 and 3 were 0.2-0.4 and MFC values were 0.4-0.8 mg/mL, respectively. The antimicrobial effects of the S. mukorossi fruit pericarp extract inhibited the growth of P. gingivalis, A. odontolyticus, F. nucleatum, and especially the C. albicans strains. S. mukorossi extract has interesting potential as an antimicrobial agent against endodontic pathogens.

🔖

Cite This Article

SAGLİK, İ., TUNCAY, Ö. G., ÖZHAK, B. (2020). Investigation of the antimicrobial effects of Sapindus mukorossi on endodontic pathogens. Journal of Experimental and Clinical Medicine, Cilt: 37 - Sayı: 4, 111–118. https://ajindex.com/articles/678134

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (7)

  1. Abou-Rass, M., & Bogen, G, 1998. Microorganisms in closed periapical lesions. International Endodontic Journal, 31(1), 39–47.
  2. Ali, M., Khan, T., Fatima, K., Ali, Q.U.A., Ovais, M., Khalil AT., Ullah I., Raza A., Shinvari Z.K., Idrees, M, 2018. Selected hepatoprotective herbal medicines: Evidence from ethnomedicinal applications, animal models, and possible mechanism of actions. Phytotherapy Research, 32, 199–215.
  3. Aligiannis, N., Kaplotzakis, E., Mitaku, S., & Chinou, I.B., 2001. Composition and antimicrobial activity of the essential oils of two Origanum species. Journal of Agriculture and Food Chemistry, 49, 4168–4170.
  4. Alves, E.G., Vinholis, A.H.C., Casemiro, L.A., Furtado, N.A.J.C., Silva, M.L.A., Cunha, W.R., 2008. Comparative study of screening techniques for antibacterial activity evaluation of plant crude extracts and pure compounds. Quimica Nova, 31(5), 1224-1229.
  5. Aneja, K.R., Joshi, R., & Sharma, C., 2010. In vitro antimicrobial activity of Sapindus mukorossi and Emblica officinalis against dental caries pathogens. Ethnobotanical Leaflets, 14, 402–412.
  6. Caetano da Silva S.D., Mendes de Souza, M.G., Oliveira Cardoso, M.J., da Silva Moraes, T., Ambrósio, S.R., Sola Veneziani, R.C., & Martins, C.H., 2014. Antibacterial activity of Pinus elliottii against anaerobic bacteria present in primary endodontic infections. Anaerobe, 30, 146–152.
  7. Castilho, A.L., Saraceni, C.H., Díaz, I.E., Paciencia, M.L., & Suffredini, I.B., 2013. New trends in dentistry: Plant extracts against Enterococcus faecalis. The efficacy compared to chlorhexidine. Brazilian Oral Research, 27(2), 109–115. Clinical and Laboratory Standards Institute., 2015. Performance Standards for Antimicrobial Disk Susceptibility Tests; Approved Standard—Twelfth Edition. M02-A12. Clinical and Laboratory Standards Institute, Wayne, PA. Clinical and Laboratory Standards Institute, 2009. Method for Antifungal Disk Diffusion Susceptibility Testing of Yeasts; Approved Guideline. CLSI document M44-A2. 2nd ed. Wayne: Clinical and Laboratory Standards Institute. Clinical and Laboratory Standards Institute, 2015. Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically; Approved Standard-tenth edition, CLSI document M07-A9. Wayne: Clinical and Laboratory Standards Institute. Clinical and Laboratory Standards Institute, 2008. Reference Method for Broth Dilution Antifungal Susceptibility Testing of Yeast; Approved Standard-Third Edition. CLSI document M27-A3. Wayne: Clinical and